IMR Press / RCM / Volume 23 / Issue 4 / DOI: 10.31083/j.rcm2304137
Open Access Review
Nonbacterial Thrombotic Endocarditis: Presentation, Pathophysiology, Diagnosis and Management
Show Less
1 Alameda Health System – Highland Hospital, Oakland, CA 94602, USA
2 Division of Cardiovascular Medicine, University of California Davis, Davis, CA 95817, USA
3 School of Medicine, University of California Irvine, Irvine, CA 92697, USA
*Correspondence: eaamsterdam@ucdavis.edu (Ezra A. Amsterdam)
These authors contributed equally.
Academic Editors: Robert C. Hendel and Patrizio Lancellotti
Rev. Cardiovasc. Med. 2022, 23(4), 137; https://doi.org/10.31083/j.rcm2304137
Submitted: 26 September 2021 | Revised: 31 December 2021 | Accepted: 13 January 2022 | Published: 11 April 2022
(This article belongs to the Special Issue State-of-the-Art Cardiovascular Medicine in the USA 2022)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Initially described in 1936, non-bacterial thrombotic endocarditis (NBTE) is a rare entity involving sterile vegetations on cardiac valves. These vegetations are usually small and friable, typically associated with hypercoagulable states of malignancy and inflammatory diseases such as systemic lupus erythematosus. Diagnosis remains challenging and is commonly made post-mortem although standard clinical methods such as echocardiography (transthoracic and transesophageal) and magnetic resonance imaging may yield the clinical diagnosis. Prognosis of NBTE is poor with very high morbidity and mortality usually related to the serious underlying conditions and high rates of systemic embolization. Therapeutic anticoagulation with unfractionated heparin has been described as useful for short term prevention of recurrent embolic events in patients with NBTE but there are no guidelines for management of this disease.

Keywords
nonbacterial thrombotic endocarditis
marantic endocarditis
Libman-Sacks endocarditis
endocarditis
Figures
Fig. 1.
Share
Back to top